Skip to content

Neomycin

Mycifradin (neomycin) is a small molecule pharmaceutical. Neomycin was first approved as Mycifradin on 1982-01-01. It is used to treat bacterial infections, bacterial skin diseases, escherichia coli infections, and hepatic encephalopathy in the USA. It is known to target extracellular calcium-sensing receptor.
Trade Name Mycifradin
Common Name Neomycin
Indication bacterial infections, bacterial skin diseases, escherichia coli infections, hepatic encephalopathy
Drug Class Antibiotics (Streptomyces strains)
Neomycin
Get full access now